Valuation: Zynex, Inc.

Market Cap 38.29L 33.99L 31.81L 28.83L 54.45L 37Cr 54.84L 3.82Cr 1.49Cr 19Cr 1.44Cr 1.41Cr 61Cr P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 3.8Cr 3.38Cr 3.16Cr 2.86Cr 5.41Cr 366.53Cr 5.45Cr 38Cr 15Cr 186.98Cr 14Cr 14Cr 601.1Cr EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.1
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/26 Issuer sale

Director

80,001 0.2633%
26/03/26 Issuer sale

Director

95,000 0.3126%
26/03/26 Issuer sale

Director

1,02,000 0.3357%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-96.26%-99.33% 16.93L
-2.98%-3.39%+20.71%+31.70% 25TCr
-2.53%-4.64%+1.84%-0.75% 16TCr
-0.42%-1.80%-9.99%+36.89% 14TCr
-0.50%-3.85%-56.37%-19.05% 6.14TCr
-0.86%-1.82%+12.96%+17.34% 5.03TCr
+1.66%-1.55%-20.09%-20.26% 4.67TCr
-1.00%-3.26%+19.57%+53.05% 4.83TCr
+0.02%+1.77%-5.42%+35.26% 4.59TCr
-0.84%-1.54%+33.21%+63.21% 4.32TCr
Average +0.06%-4.39%-9.98%+9.81% 8.45TCr
Weighted average by Cap. -1.23%-2.77%+2.86%+22.22%

Financials

2023 2024
Net sales 18Cr 16Cr 15Cr 14Cr 26Cr 1.78TCr 26Cr 183.9Cr 72Cr 906.44Cr 69Cr 68Cr 2.91TCr 19Cr 17Cr 16Cr 14Cr 27Cr 1.85TCr 28Cr 191.92Cr 75Cr 945.94Cr 72Cr 71Cr 3.04TCr
Net income 97.32L 86.39L 80.85L 73.28L 1.38Cr 94Cr 1.39Cr 9.71Cr 3.78Cr 48Cr 3.65Cr 3.57Cr 153.86Cr 29.94L 26.58L 24.87L 22.54L 42.57L 29Cr 42.88L 2.99Cr 1.16Cr 15Cr 1.12Cr 1.1Cr 47Cr
Net Debt 3.16Cr 2.8Cr 2.62Cr 2.38Cr 4.49Cr 304.51Cr 4.52Cr 32Cr 12Cr 155.34Cr 12Cr 12Cr 499.4Cr 3.42Cr 3.04Cr 2.84Cr 2.57Cr 4.86Cr 329.62Cr 4.9Cr 34Cr 13Cr 168.15Cr 13Cr 13Cr 540.56Cr
Projected Income Statement - Annual - Zynex, Inc.
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock